Protein Genomics, Inc.

Dr. Burt Ensley, Director
Suite W7
928-203-4127
www.proteingenomics.com |e-mail

Protein Genomics designs and manufactures sophisticated, high performance biopolymers at low cost and in large quantities for the wound healing, tissue regeneration, dermal filler and personal care markets.  They currently produce human tropoelastin (Elastatropin®) and human keratin (Keracyte®) for over the counter (OTC) and wound closure applications. These unique biomaterials were prohibitively expensive until we developed low cost manufacturing methods. Other, similar biopolymers are in the development stage.  They design these materials at the genetic (DNA) level, and can produce customized structural proteins that precisely follow human genetic profiles.

Protein Genomics was originally formed in 1993 in Princeton, New Jersey to capitalize on opportunities presented by rapid progress in the fields of genomics, the study of the structure and function of genetic material, and proteomics, the systematic analysis of protein expression in healthy and diseased tissue. These scientific tools are being used to design entirely unique products with enhanced performance in the areas of personal care and wound healing.

BURT D. ENSLEY, PhD. has been a Director of the Company since its inception in 1993. From 2000 to 2004, Dr. Ensley has served as the VP of Research and President of NuCycle Therapy, a subsidiary of Integrated BioPharma, (INB). From 1993 through 2000, Dr. Ensley was President, Chief Executive Officer and Director of Phytotech, Inc. A phytoremediation company. Phytotech was sold in 2000. From 1989 through 1992, Dr. Ensley served as Director of Advanced Technology at Envirogen, Inc., a microbial based bioremediation company. From 1981 to 1989, Dr. Ensley headed the Specialty Chemicals Group at Amgen, Inc.

Dr. Ensley received a B.S. and M.S. in Biology from the University of New Mexico and a Ph.D. in Microbiology from the University of Georgia in 1979. Since 1996, Dr. Ensley served on the National Science Foundation’s BIO Directorate Advisory Board and as a Fellow of the American Academy of Microbiology.